Ignite Creation Date:
2024-05-05 @ 10:17 PM
Last Modification Date:
2024-10-26 @ 10:16 AM
Study NCT ID:
NCT01071993
Status:
TERMINATED
Last Update Posted:
2017-12-04
First Post:
2010-02-18
Brief Title:
Efficacy of Statins In Prevention of CIN
Sponsor:
University of Oklahoma
Organization:
University of Oklahoma
Study Overview
Official Title:
Efficacy Of Statins In The Prevention of Contrast-Induced Nephropathy in Patients With Chronic Renal Insufficiency SCIN Trial A Double-Blind Placebo-Controlled Trial
Status:
TERMINATED
Status Verified Date:
2017-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Sponsor can not supply drugs anymore
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
SCIN
Brief Summary:
To determine if statin therapy plus intravenous normal saline in patients with chronic renal insufficiency undergoing angiography is superior to placebo plus intravenous normal saline therapy in the prevention of CIN
Detailed Description:
Due to the conflict in the available data there are no practice guidelines that are established in order to prevent contrast-induced nephropathy CIN Our goal is to determine if statin therapy plus intravenous normal saline in patients with chronic renal insufficiency undergoing angiography is superior to placebo plus intravenous normal saline therapy in the prevention of CIN
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None